Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 3, 2003, Pages 471-477

  Li, Yu Jun ^a   Meng, Yun Xiao ^a   Ji, Xiang Rui ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Cadherin; Catenin; Immunohistochemistry; Metastases; Pancreatic neoplasms; Prognosis

Indexed keywords

ALPHA CATENIN; CYCLINE; UVOMORULIN;

ACINAR CELL; ARTICLE; CANCER CELL; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LYMPH NODE METASTASIS; PANCREAS CANCER; PANCREAS CELL; PANCREAS DUCT; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGED; ALPHA CATENIN; CADHERINS; CARCINOMA, PANCREATIC DUCTAL; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0041409801     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Beavon IR. The E-cadherin-catenin complex in tumor metastasis: structure, function and regulation. Eur J Cancer 2000;36:1607-1620.
2. Korn WM. Moving toward and understanding of the metastatic process in hepatocellular carcinoma. World J Gastroenterol 2001;7:777-778.
3. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000;10:415-433.
4. Bair EL, Massey CP, Tran NL, et al. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocuitures of malignant oral squamous cell carcinoma cells and dermal firoblasts. Exp Cell Res 2001;270:259-267.
5. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-339.
6. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene. Trends Biochem Sci 1999;24:73-76.
7. van Aken E, De Wever O, Correia da Rocha AS, et al. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 2001;439:725-751.
8. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000;87:992-1005.
9. Debruyne P, Vermeulen S, Mareel M. The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg 1999;62:393-402.
10. Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 1999;18:15-30.
11. EI-Bahrawy MA, Pignatelli M. E-cadherin and catenins: molecules with versatile roles in normal and neoplastic epithelial cell biology. Microsc Res Tech 1998;43:224-232.
12. Bremnes RM, Veve R, Hirsch FR, et al. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002; 36:115-124.
13. Berx G, van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001;3:289-293.
14. Nollet F, Berx G, van Roy F. The role of the E-cadherin/catenin complex in the development and progression of cancer. Mol Cell Biol Res Commun 1999;2:77-85.
15. Kitagawa T, Matsumoto K, Nagafuchi A, et al. Co-expression of E-cadherin and alpha-catenin molecules in colorectal cancer. Surg Today 1999;29:511-518.
16. Joo YE, Rew JS, Park CS, et al. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma. Pancreatology 2002;2:129-137.
17. Lowy AM, Fenoglio-Preiser C, Kim OJ, et al. Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma. Ann Surg Oncol 2003;10:284-290.
18. Giulianotti PC, Boggi U, Fornaciari G. Prognostic value of histological grading in ductal adenocarcinoma of the pancreas. Int J Pancreatol 1995;17:279-289.
19. Jawhari A, Jordan S, Poole S, et al. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric cancer: relationship with patient survival. Gastroenterology 1997;112:46-54.
20. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;549:3845-3852.
21. Dai D, Chen J, Xu H. The clinical significance of E-cadherin and alpha-catenin expression in human gastric cancer. Zhonghua Zhong Liu Za Zhi 2001;23:35-38.
22. Karayiannakis AJ, Syrigos KN, Polychronidis A, et al. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis. Anticancer Res 2001;21:4127-34.
23. Karayiannakis AJ, Syrigos KN, Chatzigianni E, et al. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res 1998;18:4177-4180.
24. Gunji N, Oda T, Todoroki T, et al. Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis. Cancer 1998;82:1649-1656.
25. Gabbert HE, Mueller W, Schneiders A, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 1996;69:184-189.
26. Gofuku J, Shiozalki H, Tsujinaka T, et al. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma: Correlation with cancer invasion and metastasis. Am J Clin Pathol 1999;111:29-37.